However, some additional apoptotic/anti-apoptotic factors (Bax, Fas ligand and the inhibitor of apoptosis family members, IAPs) may also be involved in HGF-mediated survival of sorafenib-treated renal cancer cells50–52. This evidence concerns the gene FAS and renal carcinoma.